KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 0.23%.

  • Gilead Sciences' Return on Capital Employed rose 2100.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year increase of 2100.0%. This contributed to the annual value of 0.03% for FY2024, which is 1100.0% down from last year.
  • Latest data reveals that Gilead Sciences reported Return on Capital Employed of 0.23% as of Q3 2025, which was up 2100.0% from 0.18% recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Return on Capital Employed registered a high of 0.23% during Q3 2025, and its lowest value of 0.02% during Q3 2024.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.15% (2023), whereas its average is 0.13%.
  • As far as peak fluctuations go, Gilead Sciences' Return on Capital Employed tumbled by -1400bps in 2024, and later skyrocketed by 2100bps in 2025.
  • Gilead Sciences' Return on Capital Employed (Quarter) stood at 0.18% in 2021, then dropped by -20bps to 0.14% in 2022, then grew by 5bps to 0.15% in 2023, then plummeted by -75bps to 0.04% in 2024, then skyrocketed by 530bps to 0.23% in 2025.
  • Its Return on Capital Employed was 0.23% in Q3 2025, compared to 0.18% in Q2 2025 and 0.18% in Q1 2025.